Eric Sabbah
Impact in
-
- Antiplatelet Therapy and Cardiovascular Diseases
- Heart Failure Treatment and Management
- Acute Myocardial Infarction Research
- Surgery top 10%
- Lipoproteins and Cardiovascular Health
- Coronary Interventions and Diagnostics
Papers in
- Surgery 6
- Lipoproteins and Cardiovascular Health 6
-
- Heart Failure Treatment and Management 2
- Antiplatelet Therapy and Cardiovascular Diseases 1
Eric Sabbah
9 papers receiving 695 citations
Eric Sabbah's Hit Papers
Peers
Comparison fields: 5 of 43
- Cardiology and Cardiovascular Medicine 247
- Surgery 402
- Endocrinology, Diabetes and Metabolism 100
- Nephrology 12
- Immunology 20
Countries citing papers authored by Eric Sabbah
This map shows the geographic impact of Eric Sabbah's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric Sabbah with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric Sabbah more than expected).
Fields of papers citing papers by Eric Sabbah
This network shows the impact of papers produced by Eric Sabbah. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric Sabbah. The network helps show where Eric Sabbah may publish in the future.
No co-authors to show.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial Hit paper breakdown → | 2019 | 244 |
| 2 | 2019 | 160 | |
| 3 | 2021 | 116 | |
| 4 | 2022 | 78 | |
| 5 | 2020 | 65 | |
| 6 | 2021 | 28 | |
| 7 | Relation of Low-Density Lipoprotein Cholesterol, High-Sensitivity C-Reactive Protein, and Lipoprotein(a) Each to Future Cardiovascular Events and Death After Acute Coronary Syndrome on High-Intensity Statin Therapy: An Analysis of the Placebo Arm of ODYSSEY OUTCOMES Hit paper breakdown → | 2025 | 19 |
| 8 | 2025 | 19 | |
| 9 | 2024 | 15 |
About Eric Sabbah
Eric Sabbah is a scholar working on Surgery, Cardiology and Cardiovascular Medicine, Nuclear Energy and Engineering, Waste Management and Disposal and Infectious Diseases, having authored 9 papers that have together received 744 indexed citations. Recurring topics across this work include Lipoproteins and Cardiovascular Health (6 papers), Heart Failure Treatment and Management (2 papers) and Antiplatelet Therapy and Cardiovascular Diseases (1 paper). The work is most often cited by research in Cardiology and Cardiovascular Medicine (247 citations), Surgery (402 citations), Endocrinology, Diabetes and Metabolism (100 citations), Nephrology (12 citations) and Immunology (20 citations). Their work appears in journals such as The Lancet, Circulation, European Heart Journal - Cardiovascular Pharmacotherapy, Diabetes Care and Journal of the American College of Cardiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.